Vitamin D3 (Cholecalciferol)

Origin of Ingredient

Food-derived, fermentation-derived or manufactured vitamin form produced to a defined potency specification.

History of Ingredient

Vitamin D3 (Cholecalciferol) developed from nutrition and deficiency research and is now used as a defined nutrient form in supplements. Bioavailability and legal conditions can differ between chemical forms.

Scientific Makeup of Ingredient

Vitamin D provided in the named chemical or coenzyme form; potency is expressed according to the relevant nutrient convention.

UK Legal Claim

• Vitamin D contributes to normal absorption/utilisation of calcium and phosphorus.
• Vitamin D contributes to normal blood calcium levels.
• Vitamin D contributes to the maintenance of normal bones.
• Vitamin D contributes to the maintenance of normal muscle function.
• Vitamin D contributes to the maintenance of normal teeth.
• Vitamin D contributes to the normal function of the immune system.
• Vitamin D has a role in the process of cell division. Conditions: Finished product must qualify as a source of the nutrient and meet the exact conditions of use in the current GB/EU register. Confirm the amount supplied by the recommended daily portion.

EU Legal Claim

• Vitamin D contributes to normal absorption/utilisation of calcium and phosphorus.
• Vitamin D contributes to normal blood calcium levels.
• Vitamin D contributes to the maintenance of normal bones.
• Vitamin D contributes to the maintenance of normal muscle function.
• Vitamin D contributes to the maintenance of normal teeth.
• Vitamin D contributes to the normal function of the immune system.
• Vitamin D has a role in the process of cell division. Conditions: Finished product must qualify as a source of the nutrient and meet the exact conditions of use in the current GB/EU register. Confirm the amount supplied by the recommended daily portion.

US Legal Claim

FDA does not pre-approve ordinary dietary-supplement structure/function claims. Example for regulatory review only (NOT FDA-approved wording): “Supports normal bone health.” The marketer must hold substantiation, avoid disease claims, use the DSHEA disclaimer and notify FDA within 30 days after first marketing.

00:00:00

August 24, 2024

Fast Response